Special Oversight Of Gene Therapies To Be Rolled Back As Treatment Becomes More Commonplace

Experts are wary because while the therapies have provided some miraculous success, there have also been spectacular failures. Health officials, however, say that the FDA can provide enough oversight and extra supervision from the NIH is no longer needed.

from Kaiser Health News https://ift.tt/2wd4FEQ